Organic electroluminescent materials and devices

US2017229663A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017229663-A1
Application numberUS-201715407337-A
CountryUS
Kind codeA1
Filing dateJan 17, 2017
Priority dateFeb 9, 2016
Publication dateAug 10, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel Iridium complexes having three different bidentate ligands useful for phosphorescent emitters in OLEDs are disclosed. At least one of the three different bidentate ligands is a carbene ligand.

First claim

Opening claim text (preview).

1 . A compound having a formula M(L A ) x (L B ) y (L C ) z : wherein the ligand L A is the ligand L B is and the ligand L C is wherein M is a metal having an atomic number greater than 40; wherein x is 0, 1, or 2; wherein y is 1, 2, or 3; wherein z is 0, 1, or 2; wherein x+y+z is the oxidation state of the metal M; wherein L A is different from L B , and when x, y, or z is larger than 1, each plurality of L A , L B , or L C are also different; wherein rings A, B, C, and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; wherein R A , R B , R C , and R D each independently represent mono substitution up to the maximum possible number of substitutions, or no substitution; wherein Z 1 and Z 2 are each independently selected from the group consisting of carbon or nitrogen; wherein C 1 is an anionic donor carbon atom, C 2 is a neutral carbene carbon atom; wherein each of R A , R B , R C , R D , R X , R Y , and R Z are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any adjacent substitutents substituents are optionally joined or fused into a ring. 2 . The compound of claim 1 , wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. 3 . The compound of claim 1 , wherein M is Ir or Pt. 4 . The compound of claim 1 , wherein Z 1 is a neutral donor nitrogen atom, Z 2 is an anionic donor carbon atom. 5 . The compound of claim 1 , wherein rings A, B, and C are 6-membered aromatic rings, and ring D is a 5-member aromatic rings. 6 . The compound of claim 1 , wherein Rings B and C are benzene. 7 . The compound of claim 1 , wherein the compound is selected from the group consisting of: Ir(L A )(L B )(L C ), Ir(L A )(L B ) 2 , Ir(L A ) 2 (L B ),Pt(L A )(L B ), and Pt(L B ) 2 . 8 . The compound of claim 1 , wherein the ligand L A is selected from the group consisting of: wherein each X 1 to X 17 are independently selected from the group consisting of carbon and nitrogen; wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO 2 , CR′R″, SiR′R″, and GeR′R″; wherein R′ and R″ are optionally fused or joined to form a ring; wherein each R a , R b , R c , and R d may represent from mono substitution up to the maximum possible number of substitutions, or no substitution; wherein R′, R″, R a , R b , R c , and R d are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents of R a , R b , R c , and R d are optionally fused or joined to form a ring or form a multidentate ligand. 9 . The compound of claim 1 , wherein the ligand L B is selected from the group consisting of: wherein each X 1 to X 8 are independently selected from the group consisting of carbon and nitrogen; wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO 2 , CR′R″, SiR′R″, and GeR′R″; wherein R′ and R″ are optionally fused or joined to form a ring; wherein each R a , R b , R c , and R d may represent from mono substitution up to the maximum possible number of substitutions, or no substitution; wherein R′, R″, R a , R b , R c , and R d are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents of R a , R b , R c , and R d are optionally fused or joined to form a ring or form a multidentate ligand. 10 . The compound of claim 1 , wherein the ligand L C has the formula: wherein R X1 , R X2 , R Z1 , and R Z2 are independently selected from group consisting of alkyl, cycloalkyl, aryl, and heteroaryl; wherein at least one of R X1 , R X2 , R Z1 , and R Z2 has at least two carbon atoms. 11 . The compound of claim 1 , wherein the ligand L A is selected from the group consisting of: wherein each R a , R b , R c , and R d may represent from mono substitution up to the maximum possible number of substitutions, or no substitution; wherein R a , R b , R c , and R d are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents of R a , R b , R c , and R d are optionally fused or joined to form a ring or form a multidentate ligand. 12 . The compound of claim 1 , wherein the ligand L A is selected from the group consisting of:

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017229663A1 cover?
Novel Iridium complexes having three different bidentate ligands useful for phosphorescent emitters in OLEDs are disclosed. At least one of the three different bidentate ligands is a carbene ligand.
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Aug 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).